Cumberland Pharmaceuticals Inc. Remaining Share Repurchase Authorization
Cumberland Pharmaceuticals Inc. (CPIX) had Remaining Share Repurchase Authorization of $2.10 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2026-08-07
- 2026-06-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $2.10M.
- 2026-03-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $2.10M.
- 2025-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $2.20M.
- 2025-09-30: Stock Repurchase Program, Remaining Authorized Repurchase Amount $2.20M.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2026-06-30 | $2.10M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $2.10M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $2.20M 10-K · filed 2026-03-09 |
| 2025-09-30 | $2.20M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $2.20M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.20M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $2.40M 10-K · filed 2025-03-07 |
| 2024-09-30 | $2.50M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.60M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $2.80M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $3.00M 10-K · filed 2024-03-13 |
| 2022-12-31 | $3.80M 10-K · filed 2023-03-13 |
| 2021-12-31 | $4.80M 10-K · filed 2022-03-11 |
| 2020-12-31 | $6.20M 10-K · filed 2021-03-12 |
| 2019-12-31 | $8.00M 8-K · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |